Solana-Altabella, Antonio; Iniesta-Navalón, Carles; Chovi-Trull, María; Rodríguez-Veiga, Rebeca; López-Nogueroles, Marina; Martínez-Cuadrón, David; Gil-Candel, Mayte; Torres-Miñana, Laura; Acuna-Cruz, Evelyn; Cano-Ferri, Isabel; Boluda, Blanca; Navarro-Vicente, Irene; Lloret-Madrid, Pilar; Barragán, Eva; Gil, José-Vicente; Rodenas-Rovira, Mario; Megias-Vericat, Juan-Eduardo; Labrador, Jorge; Peris-Ribera, José-Esteban; Poveda-Andres, José-Luis; Montesinos, Pau
(SPRINGER, 2025-11)
PURPOSE: Quizartinib pharmacokinetics in FLT3-ITD negative acute myeloid leukemia (AML) remain largely unexplored. This study aims to validate a population pharmacokinetics model (popPK) for quizartinib in plasma samples ...